1) N-terminal fragment of human LBP
N-末端脂多糖结合蛋白
1.
Prokaryotic expression and antigenicity analysis of N-terminal fragment of human LBP
人源N-末端脂多糖结合蛋白(NH-LBP)的原核表达及抗原性分析
2) NH terminal lipopolysaccharide binding protein
N端脂多糖结合蛋白
3) human N terminal lipopolysaccharide binding protein
人源氨基末端脂多糖结合蛋白
4) N-terminal fragment of human lip polysaccharide binding protein
人氨基末端脂多糖结合蛋白
1.
Objective To obtain the disulfide stabilized Fv fragment (dsFv) against N-terminal fragment of human lip polysaccharide binding protein (NH-LBP) and to identify its biological vitality.
目的制备抗人氨基末端脂多糖结合蛋白(N-terminal fragment of human lipopolysaccharide binding protein,NH-LBP)的二硫键稳定性Fv抗体(disulfide stabilized Fv fragment,dsFv),并初步测定其生物学活性。
5) lipopolysaccharide binding protein
脂多糖结合蛋白
1.
The Levels of Endotoxin and Lipopolysaccharide Binding Protein in Patients with Cirrhosis and their Relevance to the Prognosis;
肝硬化患者的内毒素和脂多糖结合蛋白水平及其与预后的关系
2.
Screening of peptide mimicking antiinflammatory functional site of lipopolysaccharide binding protein by phage peptide library;
噬菌体展示短肽模拟脂多糖结合蛋白抗炎功能位点的研究
3.
After 4 weeks therapy, changes of the intestinal flora and lipopolysaccharide binding protein (LBP) of .
选择24名正常人为对照组,计数肠道菌群中5种细菌的数量;60例肝硬化患者随机分成常规治疗组(28例)及蜡样芽孢杆菌微生态治疗组(32例),分别治疗4w,观察治疗前后肠道菌群落计数及血清脂多糖结合蛋白(LBP)的变化。
6) N terminal fragment of human lipopolysaccharide binding protein
脂多糖结合蛋白氨基端片段
1.
Reconstruction,expression and characterization of dsFv V_L of human antibody to N terminal fragment of human lipopolysaccharide binding protein;
抗人脂多糖结合蛋白氨基端片段抗体dsFv V_L链的构建、表达和鉴定
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条